|
|||||
|
|
CMV high-risk status and posttransplant outcomes in kidney transplant recipients treated with belatacept |
|
| Authors: | Geeta Karadkhele Julien Hogan Wairimu Magua Weiwen Zhang Idelberto Raul Badell Aneesh Mehta Marshall Lyon Stephen Pastan Thomas C. Pearson Christian P. Larsen |
| Affiliation: | 1. Department of Surgery, Emory Transplant Center, Emory School of Medicine, Atlanta, Georgia, USA;2. Infectious Diseases Department, Department of Medicine, Emory School of Medicine, Atlanta, Georgia, USA |
| Abstract: | |
| Keywords: | clinical research/practice complication: infectious immunosuppressant - fusion proteins and monoclonal antibodies: belatacept immunosuppression/immune modulation immunosuppressive regimens - maintenance infection and infectious agents - viral: Cytomegalovirus (CMV) infectious disease kidney (allograft) function/dysfunction kidney transplantation/nephrology translational research/science |